Untitled

In June 2018, following a lengthy process of research and clinical trials, the FDA approved the use of CBD to treat two rare and severe types of epilepsy that do not respond well to other treatments.

The first new drug approval was for Cloquet, a topical formulation that contains CBD, the non-psychoactive chemical compound found in the marijuana plant. The second new drug approval was for Rizatriptan, a new form of anticonvulsant medicine that contains CBD. If you want to learn more about similar products, learn about about heavy yield seeds here.

The FDA has granted a new marketing authorization for CBD, a derivative of cannabis that is used to treat intractable epilepsy, in a bottle containing 150 mg of the product per daily dose. The new marketing authorization is for children with Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DST) which are rare epilepsy disorders that do not respond well to anticonvulsant drugs. The new drug approval is not for patients with epilepsy on medication. The product does not contain cannabis, or any other ingredients, that are prohibited by the federal Controlled Substances Act.”

How to Find a Medical Marijuana Doctor | Leafly

So, as you can see, the FDA clearly made a decision to do just that, at least according to the wording of the new labeling. If the federal government wants to classify cannabis as an illegal substance (or something worse than it has ever been), it is free to do so, just as long as it doesn’t do it by regulating anything at all.

The government could be completely and totally wrong, and the cannabis plant could become more widely accepted as a valuable medicine. The FDA should wait until such time as the science on cannabis as medicine is properly studied. It’s clear that the federal government’s decision to keep cannabis illegal is due to the belief that the plant is less harmful than the drugs it’s classified as a controlled substance. It is also clear that they believe that the cannabis plant is less dangerous than alcohol, cigarettes, and other drugs. In fact, the Food and Drug Administration regulates more drugs than marijuana. There’s just no evidence that the FDA or any other regulatory body is a more reliable watchdog than the scientific community.

 

Liked it? Take a second to support Mike Kurylo on Patreon!

Mike Kurylo

Mike Kurylo is the founder and editor of KnickerBlogger.net. His book on the 2012 Knicks, "We’ll Always Have Linsanity," is on sale now. Follow him on twitter (@KnickerBlogger).

9 thoughts to “Untitled”

  1. His game itself is no better than it was. He’s always been immensely talented. His decision making (or is it fear of the wrath of Larry?) has improved monumentally, I’d say, simply by his increased FT attempts and his hesitation to jack up fadeaway threes.

  2. I think he’s certainly starting to improve from last season (not that that’s saying much). He’s taking 4.5 less shots per game (4.4 less 3s). His field-goal% is much improved at .433 (although his eFG% is understandably down), and he is getting as many points per shot as Channing Frye. While he may not be Ron Artest, he’s putting in some effort on the defensive end. The early season was a bit rocky for the entire team, but Crawford’s had two very impressive games back-to-back. Of course, two games are not 82 games.

  3. Forget the comeback. The best moment of the night was Mike BreenOnHand’s instant classic…

    “You go, dawg”

    Anyone who heard him say this just before half time knows what I mean.

  4. I think he’s improved a bit, but still has a long way to go. His shot selection is better generally, but he has games where he reverts to his old habits.

    Actually the Memphis piece in the NY Sun earlier this week was going to be a piece on the new and somewhat improved Jamal Crawford, but then came that 5-17 stinker over the weekend and it looked like the chuck n duck version of Crawford was back.

    -MJ

  5. Just as a little gift for those that get this far, the pace & 4 factors of the Knicks/Bulls game:

    Team   PTS  POSS  eFG%  TO%   REB%  FTFG
    Bulls  101  94.1  54.6  20.2  21.6  23.7
    Knicks 109  93.2  49.2  17.2  26.5  69.2
  6. ?You go, dawg?

    …mike breen is terrible and should go back to hockey because he knows nothing about b-ball; states the obvious all the time, uninsighful commentary, has nothing more than a rudimentary knowledge of b-ball; the avg. fan knows more than him.

  7. Greetings,
    I am a 35 year old with twin boys. I grew up watching/playing baseball and hockey (NYRangers Boston Red Sox) but just never got into basketball. But as my sons get older, I am sure they will take an interest in it as it’s a very popular sport around us. I have tried watching a few Knicks games this year to see if I could ‘get into it’. The game wasn’t overly difficult to follow but I found a lot of the terminolgy and abbreviations confusing. Would anyone have any suggestions as to how to learn more about the game, what all the stats/terms/abbreviations mean, etc?

    Thanks for your time,
    Chaim

Comments are closed.